Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$29.90
-1.1%
$30.63
$25.73
$48.76
$1.29B1.32394,605 shs322,506 shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$12.89
-10.0%
$11.04
$8.27
$30.10
$429.45M1.31683,065 shs625,013 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$15.44
-0.4%
$21.61
$14.75
$30.02
$1.24B1.072.96 million shs2.20 million shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$27.83
+3.1%
$25.59
$19.35
$65.65
$1.54B0.851.42 million shs1.06 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
+3.33%-5.54%+1.43%-30.54%-11.25%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
+7.67%+16.99%+29.01%+43.20%+10.24%
National Vision Holdings, Inc. stock logo
EYE
National Vision
-7.07%-10.82%-30.93%-44.44%-25.80%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
+2.54%-0.74%+7.23%+11.48%-56.19%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$29.90
-1.1%
$30.63
$25.73
$48.76
$1.29B1.32394,605 shs322,506 shs
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$12.89
-10.0%
$11.04
$8.27
$30.10
$429.45M1.31683,065 shs625,013 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$15.44
-0.4%
$21.61
$14.75
$30.02
$1.24B1.072.96 million shs2.20 million shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$27.83
+3.1%
$25.59
$19.35
$65.65
$1.54B0.851.42 million shs1.06 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
+3.33%-5.54%+1.43%-30.54%-11.25%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
+7.67%+16.99%+29.01%+43.20%+10.24%
National Vision Holdings, Inc. stock logo
EYE
National Vision
-7.07%-10.82%-30.93%-44.44%-25.80%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
+2.54%-0.74%+7.23%+11.48%-56.19%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.43
Hold$39.7532.94% Upside
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.33
Hold$18.0039.64% Upside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.58
Moderate Buy$30.0894.84% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.43
Hold$41.4548.96% Upside

Current Analyst Ratings Breakdown

Latest CLPT, PRCT, EYE, and CDRE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
DowngradeHold (C+)Hold (C)
5/15/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Lower Price TargetBuy$40.00 ➝ $39.00
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
UpgradeHold (C-)Hold (C)
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Set Price Target$25.00
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Lower Price TargetBuy$42.00 ➝ $36.00
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Lower Price TargetEqual Weight$30.00 ➝ $22.00
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Lower Price TargetOverweight$38.00 ➝ $27.00
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Lower Price TargetEqual Weight$30.00 ➝ $20.00
5/14/2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
Lower Price TargetBuy$35.00 ➝ $30.00
5/13/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Reiterated RatingBuy$40.00
5/13/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Set Price Target$40.00
(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$610.31M2.10$1.59 per share18.81$7.82 per share3.82
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$36.97M10.46N/AN/A$0.99 per share13.02
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.99B0.62$1.78 per share8.66$10.96 per share1.41
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$308.05M5.14N/AN/A$6.55 per share4.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$44.14M$0.8933.6021.061.015.80%12.39%5.08%8/4/2026 (Estimated)
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$25.54M-$1.01N/AN/AN/A-71.57%-140.96%-36.98%8/11/2026 (Estimated)
National Vision Holdings, Inc. stock logo
EYE
National Vision
$29.60M$0.5727.0919.061.322.31%6.41%2.81%8/5/2026 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$95.57M-$1.82N/AN/AN/A-31.82%-27.70%-20.29%8/5/2026 (Estimated)

Latest CLPT, PRCT, EYE, and CDRE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.28-$0.32-$0.04-$0.32$11.97 million$12.13 million
5/13/2026Q1 2026
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.43$0.45+$0.02$0.38$545.09 million$543.88 million
4/29/2026Q1 2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.55-$0.56-$0.01-$0.56$80.52 million$83.13 million
3/17/2026Q4 2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.22-$0.27-$0.05-$0.27$10.40 million$10.41 million
3/10/2026Q4 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.47$0.27-$0.20$0.27$182.94 million$167.22 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.401.34%N/A44.94%2 Years
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A

Latest CLPT, PRCT, EYE, and CDRE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/21/2026
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.101.34%5/1/20265/1/20265/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
1.04
2.26
1.33
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.63
5.79
4.88
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.25
0.62
0.37
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.15
6.73
5.51

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
30.10%
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.94%
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.40%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
6.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,53342.80 million29.92 millionOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11029.99 million27.91 millionOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,13880.12 million78.19 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43056.92 million53.16 millionOptionable

Recent News About These Companies

PROCEPT BioRobotics (PRCT) Receives a Buy from TD Cowen

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cadre stock logo

Cadre NYSE:CDRE

$29.90 -0.34 (-1.12%)
Closing price 03:59 PM Eastern
Extended Trading
$30.00 +0.10 (+0.33%)
As of 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$12.89 -1.43 (-9.99%)
Closing price 04:00 PM Eastern
Extended Trading
$12.80 -0.09 (-0.67%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

National Vision stock logo

National Vision NASDAQ:EYE

$15.44 -0.06 (-0.39%)
Closing price 04:00 PM Eastern
Extended Trading
$15.31 -0.13 (-0.86%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$27.83 +0.83 (+3.07%)
Closing price 04:00 PM Eastern
Extended Trading
$27.76 -0.07 (-0.25%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.